Chief Financial Officer and Head of Service Delivery
George Cardoza is Biocartis’ Chief Financial Officer and Head of Service Delivery since 7 August 2023. Mr. Cardoza is responsible for overseeing the company's financial strategies, driving operational efficiencies, and ensuring sustainable growth in line with the organization's objectives. In addition, Mr. Cardoza will oversee the execution of Biocartis’ strategic partnerships. Mr. Cardoza has more than 25 years of experience in the diagnostics and laboratory industry and brings a unique combination of extensive experience in both finance and operational leadership roles. Prior to joining Biocartis, Mr. Cardoza served as CEO of AccuraGen Holdings LLC, a California-based company focused on development of NGS-based liquid biopsy testing and prior to that he served in various executive roles (President and Chief Operating Officer Laboratory Services, President Pharma Services Division, and CFO) at NeoGenomics Laboratories (NASDAQ: NEO) a clinical laboratory and pharma services company that specialized in cancer diagnostic testing. Throughout his career, Mr. Cardoza has demonstrated a strong aptitude for financial management, strategic planning, and fostering collaboration across departments. He possesses a deep understanding of the industry landscape and a proven ability to navigate complex financial challenges while driving profitability. George Cardoza holds a B.S. in Finance and Accounting from Syracuse University and an MBA from Michigan State University. Mr. Cardoza is a US citizen.
